Is a
Patent attributes
Patent Applicant
Patent Jurisdiction
Patent Number
Date of Patent
July 25, 2023
0Patent Application Number
167287570
Date Filed
December 27, 2019
0Patent Citations
Patent Primary Examiner
The present invention provides isolated monoclonal antibodies, particularly human antibodies, that bind to IP-10 with high affinity, inhibit the binding of IP-10 to its receptor, inhibit IP-10-induced calcium flux and inhibit IP-10-induced cell migration. Nucleic acid molecules encoding the antibodies of the invention, expression vectors, host cells and methods for expressing the antibodies of the invention are also provided. Immunoconjugates, bispecific molecules and pharmaceutical compositions comprising the antibodies of the invention are also provided. The invention also provides methods for inhibiting IP-10 activity using the antibodies of the invention, including methods for treating various inflammatory and autoimmune diseases.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.